GoviEx Uranium secures backing from 40% of securityholders for reverse takeover of Tombador Iron

GoviEx Uranium has secured binding voting support from over 40% of its securityholders for its reverse takeover of Tombador Iron, a transaction expected to close in early November 2025. This deal will establish Atomic Eagle, an ASX-listed uranium developer, with GoviEx shareholders holding 75% of the new entity, aiming to advance the Muntanga project with a strengthened balance sheet. A concurrent financing of A$5 million to A$10 million at a 28% premium will boost the combined company's cash to between A$19.4 million and A$24.4 million, positioning it for growth and a planned dual listing.

Analysis

GoviEx Uranium is executing a strategic reverse takeover of Tombador Iron to form a new, ASX-listed uranium developer named Atomic Eagle, aimed at advancing its Muntanga project in Zambia. The transaction has secured significant momentum, with binding support from over 40% of GoviEx securityholders, substantially de-risking the shareholder votes scheduled for October 2025. Financially, the deal is structured to create a robust balance sheet for the new entity; a concurrent financing of A$5 million to A$10 million, priced at a notable 28% premium to GoviEx's current share price, is expected to lift the combined company's cash position to between A$19.4 million and A$24.4 million. Upon completion, GoviEx shareholders will hold a majority 75% stake in Atomic Eagle. The move to an ASX listing, with a potential secondary US OTC listing, is designed to enhance access to capital and unlock value, positioning Atomic Eagle as a more formidable player in the uranium development space.

Key Decisions for Investors

• Investors should assess the transaction based on the pro-forma valuation of Atomic Eagle, considering its enhanced cash position of up to A$24.4 million and singular focus on the Muntanga uranium project.
• The upcoming shareholder votes on October 8 and October 24, and the successful completion of the concurrent financing, are critical near-term catalysts to monitor for deal certainty before the expected close in early November.
• The financing's 28% premium to GoviEx's current share price serves as a positive valuation marker, suggesting current market prices for GXU may represent a discount relative to the placement, contingent on deal completion.
• Consider the potential for improved liquidity and valuation re-rating following the planned ASX listing and subsequent pursuit of a US listing, which could broaden the investor base for the newly formed entity.